Abstracts
Résumé
Les méthodes non invasives de mesure de la densité osseuse, appelées densitométrie, ont transformé l’approche diagnostique et thérapeutique des maladies osseuses métaboliques. De très nombreuses études cliniques ont montré les propriétés métrologiques de ces techniques et leur valeur prédictive. La technique de référence est l’absorptiométrie biphotonique à rayons X dont les résultats sont décrits dans cet article.
Summary
Measurement of bone mineral density (BMD) using dual energy X-ray absorptiometry is the basis of the definition of osteoporosis. Accuracy, precision and sensitivity of the method are good enough for clinical use. Prospective studies have shown that there is a gradient of risk between the decrease in BMD, related to age and hormonal insufficiency, and the increase in the incidence of fracture. Thus, therapeutic decision is based on both BMD and clinical risk factors that contribute to fracture risk.
Appendices
Références
- 1. Kanis JA, Gl→er CC, for the Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int 2000; 11: 192-202.
- 2. Grampp S, Lang PV, Jergas M, et al. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: short term precision in vivo and comparison to dual X-ray absorptiometry. J Bone Miner Res 1995; 10: 1566-76.
- 3. Gl→er CC, Wu CY, Jergas M, Goldstein SA, Genant HK. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 1994; 55: 46-52.
- 4. Chappard C, Laugier P, Fournier B, Roux C, Berger G. Assessment of the relationship between broadband ultrasound attenuation and bone mineral density at the calcaneum using BUA imaging and DXA. Osteoporosis Int 1997; 7: 316-22.
- 5. Roux C, Fournier B, Laugier P, et al. Broadband ultrasound attenuation imaging: a new imaging method in osteoporosis. J Bone Miner Res 1996; 11: 1112-8.
- 6. Lewis MK, Black GM, Fogelman I. Patient dose in dual X-ray absorptiometry. Osteoporosis Int 1994; 4:11-5.
- 7. Ho CHP, Kim RW, Schaffler MB, Sartoris DJ. Accuracy of dual-energy radiographic absorptiometry of the lumbar spine: a cadaver study. Radiology 1990; 176: 171-3.
- 8. Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C. Smallest detectable difference in individual bone mineral density measurements. J Bone Miner Res 1999; 14: 1449-56.
- 9. World Health Organization (WHO). Assessment of fracture risk and its application to screening for post menopausal osteoporosis: Report of a WHO study group. WHO Technical Report Series n° 843. Genève : OMS, 2000.
- 10. Ahmed AIH, Black GM, Rymer JM, Fogelman I. Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to over diagnosis? Osteoporosis Int 1997; 7: 432-8.
- 11. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997; 12: 1761-8.
- 12. Chen Z, Maricic M, Lund P, Tesser J, Gluck O. How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporosis Int 1998; 8: 423-7.
- 13. Faulkner KG, Von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densit 1999 : 3 : 343-50.
- 14. Greenspan SL, Maitland-Ramsey L, Myers E. Classification of osteoporosis in the elderly is dependent on site-specific analysis. Calcif Tissue Int 1996; 58: 409-14.
- 15. Lu Y, Genant HK, Shepherd J, et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res 2001; 16: 901-10.
- 16. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int 2001; 12: 989-95.
- 17. Moro M, Hecker AT, Bouxsein ML, Myers ER. Failure load of thoracic vertebrae correlates with lumbar bone mineral density measured by DXA. Calcif Tissue Int 1995; 56: 206-9.
- 18. Majumdar S, Genant HK. A review of the recent advances in magnetic resonance imaging in the assessment of osteoporosis. Osteoporosis Int 1995; 5: 79-92.
- 19. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Ensrud K, and the Study of Osteoporotic Fractures Research Group. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72-5.
- 20. Nevitt MC, Johnell O, Black DM, Ensrud K, Genant HK, Cummings SR, for the Study of Osteoporotic Fractures Research Group. Bone mineral density predicts non-spine fractures in very elderly women. Osteoporosis Int 1994; 4: 325-31.
- 21. Kröger H, Huopio J, Honkanen R, et al. Prediction of fracture risk using axial bone mineral density in a peri-menopausal population: a prospective study. J Bone Miner Res 1995; 10: 302-6.
- 22. Torgerson DJ, Campbell MK, Thomas RE, Reid DM. Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 1996; 11: 293-7.
- 23. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of occurrence of osteoporotic fractures. Br Med J 1996; 312: 1254-9.
- 24. Black DM, Cummings SR, Melton LJ III. Appendicular bone mineral and a woman’s lifetime risk of hip fracture. J Bone Miner Res 1992; 7: 639-45.
- 25. Hans D, Dargent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996; 348: 511-4.
- 26. Ayers M, Prince M, Ahmadi S, Baran DT. Reconciling quantitative ultrasound of the calcaneus with X-ray based measurements of the central skeleton. J Bone Miner Res 2000; 15: 1850-5.
- 27. Cummings SR, Nevitt MC, Browner WS, et al. for the Study of Osteoporotic Fractures Reseach Group. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
- 28. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998; 280: 2077-82.
- 29. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002; 17 : 1-10.
- 30. Li Z, Meredith MP, Hoseyni MS. A method to assess the proportion of treatment effect explained by a surrogate end point. Stat Med 2001; 20: 3175-88.
- 31. Cummings SR, Palermo L, Browner W, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. JAMA 2000; 283: 1318-21.
- 32. Muller R, Hildebrand T, Hauselman HJ, Ruegsegger P. In vivo reproducibility of three-dimensional structural properties of non invasive bone biopsies using 3D-pQCT. J Bone Miner Res 1996; 11: 1745-50.